We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bacterial Infection Identified as Cause of Overactive Bladder Syndrome

By LabMedica International staff writers
Posted on 28 Jul 2016
Image: The DM4000 B automated LED microscope system (Photo courtesy of Leica Microsystems).
Image: The DM4000 B automated LED microscope system (Photo courtesy of Leica Microsystems).
Overactive Bladder (OAB) is currently characterized by symptoms of urgency, with or without urgency incontinence, with increased frequency, and nocturia, and in some cases pain, in the absence of urinary tract infection (UTI) or other defined underlying pathology.

The exclusion of infection is determined by failure to isolate more than 105 colony forming units (CFU)/mL of a single species of bacteria from culture of a midstream urine (MSU) specimen and negative leukocyte esterase and/or nitrate urinalysis by dipstick.

Scientists at the University of Kent (Chatham, UK) obtained bladder biopsies from local hospitals, and a catheter specimen of urine (CSU) was obtained from female patients and a MSU from male patients and non-OAB controls. All urine samples obtained were sent for conventional urinalysis and bacteria culture at the time of collection, if a UTI was subsequently identified the sample was retrospectively removed from the study.

The bladder biopsies were sectioned and stained and the morphological characteristics of the tissue evaluated. A DM4000B upright light microscope (Leica, Wetlar, Germany) was used to image the sections. A Luciferin Luciferase Adenosine triphosphate (ATP) Bioluminiscence Assay Kit was used to quantify ATP release from intact, live, bladder urothelium. ATP-evoked luminescence was quantified using a Synergy 2 luminometer (BioTek, Winooski, USA). The scientists also performed biopsy vesicle staining, biopsy ribonucleic acid (RNA) extraction and polymerase chain reactions, urine sediment immunofluorescence and urine nucleotide and nucleoside quantification.

The team found that some OAB patients had a low-grade inflammation, which is missed by conventional tests. This low-grade inflammation may ultimately result in increased sensory nerve excitation and the symptoms of OAB. They also found that in these patients the low-grade inflammation is associated with bacteria living inside the bladder wall. This was an observational study which means that no conclusions can be drawn about cause and effect. However, the findings may prompt the clinical re-classification of OAB and inform future therapeutic strategies. These might include protracted treatment with antibiotics to alleviate the symptoms of OAB in some individuals. The study was published on June 29, 2016, in the American Journal of Physiology.

Related Links:
University of Kent
Leica
BioTek
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel

DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
PURITAN MEDICAL